(Q36920696)

17 August 2017

Enoxaparin use in the neonatal intensive care unit: experience over 8 years (English)

1 reference

17 August 2017

1 reference

Janet I Malowany

1

1 reference

17 August 2017

David C Knoppert

2

1 reference

17 August 2017

Anthony K C Chan

3

1 reference

17 August 2017

Dion Pepelassis

4

1 reference

17 August 2017

David S C Lee

5

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 September 2007

1 reference

17 August 2017

1 reference

17 August 2017

27

1 reference

17 August 2017

9

1 reference

17 August 2017

1263-1271

1 reference

Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands.

17 August 2017

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.9.1263

How I treat venous thrombosis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.9.1263

Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.9.1263

Developmental hemostasis: pro- and anticoagulant systems during childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.9.1263

Neonatal thrombosis and its treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.9.1263

The investigation and management of neonatal haemostasis and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.9.1263

Pharmacodynamic and pharmacokinetic properties of enoxaparin : implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.9.1263

Neonatal hematologic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.9.1263

Use of low molecular mass heparin (enoxaparin) in newborn infants: a prospective cohort study of 62 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.9.1263

Low molecular weight heparin in the treatment of venous and arterial thromboses in the premature infant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.9.1263

An assessment of published pediatric dosage guidelines for enoxaparin: a retrospective review

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.9.1263

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.9.1263

Heparin-induced thrombocytopenia in the pediatric intensive care unit population

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.9.1263

Low-molecular-weight heparin-induced thrombocytopenia in a child

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.9.1263

Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.9.1263

Reducing injection pain in children and adolescents with diabetes: a review of indwelling catheters

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.9.1263

Insuflon versus subcutaneous injection for cytokine administration in children and adolescents: a randomized crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.9.1263

The use of an insuflon device for the administration of G-CSF in pediatric cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.9.1263

Long-term subcutaneous morphine administration after surgery in newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.9.1263

SNAP-II and SNAPPE-II: Simplified newborn illness severity and mortality risk scores

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.9.1263

Antithrombin replacement in neonates: is there any indication?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.9.1263

Compartment syndrome in an ELBW infant receiving low-molecular-weight heparins

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.9.1263

How and when to monitor a patient treated with low molecular weight heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.9.1263

How useful is the monitoring of (low molecular weight) heparin therapy by anti-Xa assay? A laboratory perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.9.1263

Coagulation and fibrinolytic systems in the ill preterm newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.9.1263

21 January 2018

Identifiers

DOI

10.1592/PHCO.27.9.1263

1 reference

17 August 2017

1 reference